AMH, MIS

General information:

Provides information on AMH values. AMH demonstrates a number of advantages over the other markers that are being tested for ovarian reserve evaluation. The most important thing is that it is independent of hypothalamic-pituitary regulation, so it can be investigated regardless of the menstrual cycle, and its decrease may outweigh the change in other indicators.
AMH is a glycoprotein growth factor. It is produced by the granulosa cells of early maturing ovarian follicles in women and predominantly by Sertollium cells in males. The number of the earliest follicles in women at a given time is the ovarian reserve. At birth AMH levels are higher in girls, with a slight increase from the second to fourth year, after which the relatively stable younger age gradually decreases as a sign of depletion of ovarian function. In menopause, this hormone is not detected. The decline was preceded by a change in other ovarian reserve markers such as FSH and Inhibin B.

The AMH values ​​during the individual periods of the monthly cycle remain unchanged. Its levels are unaffected by hormonal changes in pregnancy. Not affected by contraceptives.

SAMPLE REQUIRED:

Venous blood in the morning in fasting

Key words:

AMH